159
Views
3
CrossRef citations to date
0
Altmetric
Basic Research

Histological and Biochemical Changes in Adult Male Rat Liver after Spinal Cord Injury with Evaluation of the Role of Granulocyte-Colony Stimulating Factor

, & ORCID Icon
Pages 395-411 | Received 01 Aug 2020, Accepted 28 Oct 2020, Published online: 06 Dec 2020

References

  • Tan J, Zhang F, Liang F, et al. Protective effects of hyperbaric oxygen treatment against spinal cord injury in rats via toll-like receptor 2/nuclear factor-κB signaling. Int J Clin Exp Pathol. 2014;7:1911–1919.
  • Laws J. Lipid accumulation,macrophage activation and liver dysfunction following spinal cord injury [Honor research thesis]. The Ohio State University; 2014:1–27
  • Garcia-Lopez P, Martinez-Cruz A, Guizar-Sahagun G, Castaneda-Hernandez G. Acute spinal cord injury changes the disposition of some, but not all drugs given intravenously. Spinal Cord. 2007;45:603–608. doi:10.1038/sj.sc.3102001.
  • Sauerbeck AD, Laws JL, Bandaru VR, Popovich PG, Haughey NJ, McTigue DM. Spinal Cord Injury Causes Chronic Liver Pathology in Rats. J Neurotrauma. 2015;32:159–169. doi:10.1089/neu.2014.3497.
  • Benomar Y, Gertler A, De Lacy P, et al. Central resistin overexposure induces insulin resistance through toll-like receptor 4. Diabetes. 2013;62(1):102–114. doi:10.2337/db12-0237.
  • Oliveira KM, Silva CM, Lavor MS, et al. Systemic effects induced by intralesional injection of ω-conotoxin MVIIC after spinal cord injury in rats. J Venomous Animals Toxins Includ Tropical Diseases. 2014;20:15. doi:10.1186/1678-9199-20-15.
  • Cragg JJ, Stone JA, Krassioukov AV. Managemen of cardiovascular disease risk factors in individuals with chronic spinal cord injury. J Neurotrauma. 2012 July 20;29(11):1999–2012. doi:10.1089/neu.2012.2313.
  • Farrell GC, van Rooyen D, Gan L, Chitturi S. NASH is an inflammatory disorder: pathogenic, prognostic and therapeutic implications. Gut Liver. 2012;6:149–171.
  • Rosselli M, Lotersztajn S, Vizzutti F, Arena U, Pinzani M, Marra F. The metabolic syndrome and chronic liver disease. Curr Pharm Des. 2014;20:5010–5024. doi:10.2174/1381612819666131206111352.
  • Sanyal AJ, Yoon SK, Lencioni R. The etiology of hepatocellular carcinoma and consequences for treatment. Oncologist. 2010;15(Suppl 4):14–22. doi:10.1634/theoncologist.2010-S4-14.
  • Baretta GAP, FilhoI OG, ToderkeI EL, TolazziII ARD, Matias JEF. Effect of cyclosporine on liver regeneration in partial hepatectomized rats. Acta Cirúrgica Brasileira. 2015;30(1):54–59.doi:10.1590/S0102-86502015001000007.
  • Lapidot T, Dar A, Kollet O. How dostem cells find their way home? Blood. 2005;106(6):1901–1910. doi:10.1182/blood-2005-04-1417.
  • Zhang L, Kang W, Lei Y, Liu Z. Granulocyte colony stimulating factor treatment ameliorates liver injury and improves survival in rats with D-galactosamine-induced acute liver failure. Toxicol Lett. 2011;204(1):92–99. doi:10.1016/j.toxlet.2011.04.016.
  • Hou JM, Greystoke A, Lancashire L, et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol. 2009;175(2):808–816. doi:10.2353/ajpath.2009.090078.
  • Menzie-Suderam J, GHaribani P, Modi J, et al. Granulocyte-Colony stimulating factor protects against endoplasmic reticulum stress in an experimental model of stroke. Brain Res. 2018;1682:1–13. doi:10.1016/j.brainres.2017.12.022.
  • Iwasaki M, Adachi Y, Minamino K, et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-induced renal failure, and M-CSF enhances the effects of G-CSF. J Am Soc Nephrol. 2005;16(3):658–666. doi:10.1681/ASN.2004010067.
  • Cho Y, Park YS, Kim HY, Kim W, Lee HJ, Kim DJ. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial. Trials. 2018;19(1):696. doi:10.1186/s13063-018-3092-7.
  • Shasthry SM, Sharma MK, Shasthry V, Pande A, Sarin SK. Efficacy of granulocyte colony stimulating factor in the management of steroid nonresponsive severe alcoholic hepatitis: A double blind randomized controlled trial. Hepatology. 2019;70(3):802–811. doi:10.1002/hep.30516.
  • Tan-Garcia A, Lai F, Yeong JP, et al. Liver fibrosis and CD206+ macrophage accumulation are suppressed by anti-GM-CSF therapy. JHEP Reports. 2020;2(1):100062. doi:10.1016/j.jhepr.2019.11.006.
  • Qujeq D, Abassi R, Faeizi F, et al. Assessment effect of granulocyte colony-stimulating factor in experimental models of liver injury. Sci Res Essays. 2011;6(21):4646–4650. doi:10.5897/SRE11.1070.
  • Zhou KI, Chen DH, Jin HM, et al. Study Effects of calcitriol on experimental spinal cord injury in rats. Spinal Cord & 2016. Int Spinal Cord Society. 2016;54:510–516. doi:10.1038/sc.2015.217.
  • Gezici AR, Kilic G, Firat T, et al. The therapeutic effects of cyclosporin-A on experimental spinal cord injury. Biomed Res. 2017;28:3755–3762.
  • Ates O, CaylI S, Altinoz E, et al. Effects of resveratrol and methylprednisolone on biochemical, neurobehavioral and histopathological recovery after experimental spinal cord injury. Acta Pharmacol Sin. 2006 Oct;27(10):1317–1325. doi:10.1111/j.1745-7254.2006.00416.x.
  • Kara A, Unal D, Simsek N, Yucel A, Yucel N, Selli J. Ultrastructural changes and apoptotic activity in cerebellum of postmenopausal- diabetic rats: a histochemical and ultra-structural study. J Gynecol Endocrinol. 2014;30(3):226–231. doi:10.3109/09513590.2013.864270.
  • Bancroft J, Layton C. The Hematoxylin and eosin. In: Suvarna SK, Layton C, Bancroft JD, eds. Theory and Practice of Histological Techniques, 7th ed. Ch. 10 and 11. Philadelphia: Churchill Livingstone of El Sevier; 2013:172–214.
  • Ramos-Vara JA, Kiupel M, Baszier T, et al. Suggested guidelines for immunohistochemical techniques in veterinary diagnostic laboratories. J Vet Diagn Invest. 2008;20:393–413. doi:10.1177/104063870802000401.
  • Hayat MA. Principles and Techniques of Electron Microscopy: Biological Applications. 4th ed. Cambridge: Cambridge Univ Press; 2000:546–558.
  • Bergmeyer H, Scheibe P, Wahlefeld A. Optimization of methods of aspartate aminotransferase and alanine aminotransferase.Clin Chem. 1978;24:58–73. doi:10.1093/clinchem/24.1.58.
  • Rojkin M, Olguim De Mariani M, Drappo G, Sosa C. Fraccionamiento proteico por determination directs de albumina. Bioq Clin. 1974a;8:241.
  • Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol. 1990;186:421–431.
  • Rojkin M, Olguim De Mariani M, Drappo G, Sosa C. Protinas totales del suero. Causas más frecuentes de error en la reaccion del biuret. Nuevo reactivo cuproalcalino estable. Bioq Del Atlántico. 1974b;6:1931–1935.
  • Flohé L, Günzler WA. Assays of glutathione peroxidase. Methods Enzymol. 1984;105:114–121.
  • Stein DM, Menaker J, McQuillan K, Handley C, Aarabi B, Scalea TM. Risk factors for organ dysfunction and failure in patients with acute traumatic cervical spinal cord injury. Neurocrit Care. 2010;13:29–39. doi:10.1007/s12028-010-9359-9.
  • Ozawa E, Abiru S, Nagaoka S, et al. Ferritin/alanine aminotransferase ratio as a possible marker for predicting the prognosis of acute liver injury. J Gastroenterol Hepatol. 2011;26(1):116–121. doi:10.1111/j.1440-1746.2011.06743.x.
  • Palipoch S, Punsawad C. Biochemical and Histological study of rat liver and kidney injury induced by cisplatin. J Toxicol Pathol. 2013;26(3):293–299. doi:10.1293/tox.26.293.
  • Lee JY, Maeng S, Kang SR, et al. Valproic acid protects motor neuron death by inhibiting oxidative stress and endoplasmic reticulum stressmediated cytochrome C release after spinal cord injury. J Neurotrauma. 2014;31:582594. doi:10.1089/neu.2013.3146.
  • Lin MH, Yang YL, Chen YP, et al. A novel exopolysaccharide from the biofilm of thermus aquaticus YT-1 induces the immune response through toll-like receptor 2. J Biol Chem. 2011;286:17736–17745. doi:10.1074/jbc.M110.200113.
  • Yang FL, Yang YL, Liao PC, et al. Structure and immunological characterization of the capsular polysaccharide of a pyrogenic liver abscess caused by Klebsiella pneumoniae. J Biol Chem. 2011;286:21041–21051. doi:10.1074/jbc.M111.222091.
  • Chen X, Yu G, Fan S, et al. Sargassum fusiforme polysaccharide activates nuclear factor kappa-B (NF-κB) and induces cytokine production via Toll-like receptors. Carbohyd Polym. 2014;105:113–120. doi:10.1016/j.carbpol.2014.01.056.
  • Trauner M, Arrese M, Wagner M. Fatty liver and lipotoxicity. Biochim Biophys Acta. 2010;1801:299–310. doi:10.1016/j.bbalip.2009.10.007.
  • Goodus MT, McTigue DM. Hepatic dysfunction after spinal cord injury: avicious cycle of central and peripheral pathology? Exp Neurol. 2020;235:113160. doi:10.1016/j.expneurol.2019.113160.
  • Sun X, Wang X, Chen T, et al. Myelin activates FAK/Akt/NF-kappaB pathways and provokes CR3-dependent inflammatory response in murine system. PLoS One. 2010;5:e9380. doi:10.1371/journal.pone.0009380.
  • Guo L, Rolfe AJ, Wang X, et al. Rescuing macrophage normal function in spinal cord injury with embryonic stem cell conditioned media. Mol Brain. 2016;9:48. doi:10.1186/s13041-016-0233-3.
  • Tosello-Trampont AC, Landes SG, Nguyen V, Novobrantseva TI, Hahn YS. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-alpha production. J Biol Chem. 2012;287:40161–40172. doi:10.1074/jbc.M112.417014.
  • Ahuja CS, Nori S, Tetreault L, et al. Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 2017;80:S9–S22. doi:10.1093/neuros/nyw080.
  • Silvestro S, Bramanti P, Trubiani O, Mazzon E. Stem cells therapy for spinal cord injury: an overview of clinical trials. Int J Mol Sci. 2020;21(2):659. doi:10.3390/ijms21020659.
  • Bedreag OH, Rogobete AF, Sărăndan M, et al. Oxidative stress and antioxidant therapy in traumatic spinal cord injuries. Rom J Anaesth Intensive Care. 2014;21:123–129.
  • Alfredo AN. Examining pathological effects of hepatic inflammation after traumatic spinal cord injury [Research Thesis]; 2016:1–28
  • Sun X, Jones ZB, Chen X, Zhou L, So K, Ren Y. Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation. 2016;13:260. doi:10.1186/s12974-016-0736-y.
  • Bhargava P, Lee CH. Role and function of macrophages in the metabolic syndrome. Biochem J. 2012;442:253–262. doi:10.1042/BJ20111708.
  • Arres M, Cabrera D, Kalergis AM, Feldstein AE. Innate immunity and inflammation in NAFLD/ NASH. Dig Dis Sci. 2016;61:1294–1303. doi:10.1007/s10620-016-4049-x.
  • Luo Y, Fu C, Wang Z, Zhang Z, Wang H, Liu Y. Mangiferin attenuates contusive spinal cord injury in rats through the regulation of oxidative stress, inflammation and the Bcl2 and Bax pathway. Mol Med Rep. 2015;12:7132–7138. doi:10.3892/mmr.2015.4274.
  • Bikman BT. A role for sphingolipids in the pathophysiology of obesity-induced inflammation. Cell Mol Life Sci. 2012;69:2135–2146. doi:10.1007/s00018-012-0917-5.
  • Prieur X, Roszer T, Ricote M. Lipotoxicity in macrophages: evidence from diseases associated with the metabolic syndrome. Biochim Biophys Acta. 2010;1801:327–337. doi:10.1016/j.bbalip.2009.09.017.
  • Pagadala M, Kasumov T, McCullough AJ, Zein NN, Kirwan JP. Role of ceramides in nonalcoholic fatty liver disease. Trends Endocrinol Metab. 2012;23(8):365–371. doi:10.1016/j.tem.2012.04.005.
  • Anthony DC, Couch Y. The systemic response to CNS injury. Exp Neurol. 2014;258:105–111. doi:10.1016/j.expneurol.2014.03.013.
  • Pruss H, Kopp MA, Brommer B, et al. Non-resolving aspects of acute inflammation after spinal cord injury (SCI): indices and resolution plateau. Brain Pathol. 2011;21:652–660. doi:10.1111/j.1750-3639.2011.00488.x.
  • Yin X, Yin Y, Cao FL, et al. Tanshinone IIA attenuates the inflammatory response and apoptosis after traumatic injury of the spinal cord in adult rats. PLoS One. 2012;7:e38381. doi:10.1371/journal.pone.0038381.
  • Ozkara E, Durmaz R, Kanbak G, et al. The effect of propolis following experimental spinal cord injury. World Spinal Column J. 2014;5:6–11.
  • Al Dera H, Habgood MD, Furness JB, Brock JA. Prominent contribution of L-type Ca2+ channels to cutaneous neurovascular transmission that is revealed after spinal cord injury augments vasoconstriction. Am J Physiol Heart Circ Physiol. 2012;302:H752–H762.
  • Xia M, Zhu Y. FOXO3a involvement in the release of TNF-alpha stimulated by ATP in spinal cord astrocytes. J Mol Neurosci. 2013;51:792–804. doi:10.1007/s12031-013-0067-8.
  • Yue C, Chen J, Hou R, et al. Effects of selenylation modification on antioxidative activities of Schisandra chinensis polysaccharide. PloS ONE. 2015;10:e0134363. doi:10.1371/journal.pone.0134363.
  • Carda AP, Marchi KC, Rizzi E, et al. Acute restraint stress induces endothelial dysfunction: role of vasoconstrictor prostanoids and oxidative stress. Stress. 2015;18:1–11. doi:10.3109/10253890.2015.1014790.
  • Li H, Jia Z, Li G, et al. Neuroprotective effects of exendin-4 in rat model of spinal cord injury via inhibiting mitochondrial apoptotic pathway. Int J Clin Exp Pathol. 2015;8:4837–4843.
  • Gokce EC, Kahveci R, Gokce A, et al. Curcumin attenuates inflammation, oxidative stress, and ultrastructural damage induced by spinal cord ischemia– reperfusion injury in rats. J Stroke Cerebrovascular Dis. 2016 May;25(5):1196–1207. doi:10.1016/j.jstrokecerebrovasdis.2016.01.008.
  • Modi J, Menzie-Suderam J, Xu H, et al. Mode of action of granulocyte-colony stimulating factor (G-CSF) as a novel therapy for stroke in a mouse model. J Biomed Sci. 2020;27(1):1–9. doi:10.1186/s12929-019-0597-7.
  • Yannaki E, Athanasiou E, Xagorari A, et al. G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs. Exp Hematol. 2005;33(1):108–119. doi:10.1016/j.exphem.2004.09.005.
  • Piscaglia ACX, Shupe TD, Oh SH, Gasbarrini A, Petersen BE. Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats. Gastroenterology. 2007;133(2):619–631. doi:10.1053/j.gastro.2007.05.018.
  • Huiling X, Inagaki M, Arikura J, et al. Hepatocytes derived from peripheral blood stem cells of granulocyte-colony stimulating factor treated F344 rats in analbuminemic rat liver. J Surg Res. 2004;122(1):75–82. doi:10.1016/j.jss.2004.05.026.
  • Gaia S, Smedile A, Omede P, et al. Feasibity and safety of G-CSF administration to induce bone marrow-derived cells mobilization in patients with end stage liver disease. J Pathol. 2006;45:13–19.
  • Omar A, Yousry MM, Farag EA. Therapeutic mechanism of granulocyte-colony stimulating factor in methotrexate-induced parotid lesion in adult rats and possible role of telocytes: A histological study. Egypt J Histol. 2018;41(4):93–107. doi:10.21608/EJH.2018.7525.
  • Chavez-Tapia NC, Mendiola-Pastrana I, Ornelas-Arroyo VJ, et al. Granulocyte-colony stimulating factor for acute-on-chronic liver failure: systemic review and meta-analysis. Ann Hepatol. 2015;14(5):631–641. doi:10.1016/S1665-2681(19)30757-4.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.